Ravenbhel Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 24 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.24 Cr
as on 24-10-2024
- Satisfied Charges ₹ 8.08 M
as on 24-10-2024
- Revenue 3.96%
(FY 2023)
- Profit -14.95%
(FY 2023)
- Ebitda -7.98%
(FY 2023)
- Net Worth 9.21%
(FY 2023)
- Total Assets 1.35%
(FY 2023)
About Ravenbhel Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.24 Cr. The company has closed loans amounting to ₹8.08 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Sharma, Yogesh Khanna, Sahil Mahajan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232PB2000PTC024120
- Company No.
024120
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Amritsar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ravenbhel Pharmaceuticals Private Limited offer?
Ravenbhel Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Herbal Capsules, Sexual Wellness Products, Female Hygiene Products & Test Kits, Herbal Oil.
Who are the key members and board of directors at Ravenbhel Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Sharma  | Director | 12-Dec-2000 | Current |
| Sanjay Khanna | Director | 12-Dec-2000 | Current |
| Sahil Mahajan | Director | 21-Aug-2019 | Current |
| Yogesh Khanna | Director | 12-Dec-2000 | Current |
| Naresh Mahajan | Director | 12-Dec-2000 | Current |
Financial Performance and Corporate Structure Insights of Ravenbhel Pharmaceuticals.
Ravenbhel Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.96% increase. The company also saw a substantial fall in profitability, with a 14.95% decrease in profit. The company's net worth moved up by a moderate rise of 9.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ravenbhel Pharmaceuticals?
In 2023, Ravenbhel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Macmillon Pharmaceuticals Private LimitedActive 36 years 3 monthsSahil Mahajan and Naresh Mahajan are mutual person
Ravenmac Pharmaceuticals Private LimitedActive 14 years 9 monthsSahil Mahajan and Naresh Mahajan are mutual person
Nys Hospitals Private LimitedActive 10 months 18 daysSanjeev Sharma, Yogesh Khanna and 2 more are mutual person
- Salutemlab Formulations Private LimitedActive 1 year 2 months
Sahil Mahajan and Naresh Mahajan are mutual person
- Salutemlife Sciences Private LimitedActive 1 year 2 months
Sahil Mahajan and Naresh Mahajan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Sep 2014 | ₹1.24 Cr | Open |
Corporation Bank Creation Date: 28 May 2014 | ₹0.79 M | Satisfied |
Corporation Bank Creation Date: 09 May 2013 | ₹0.54 M | Satisfied |
How Many Employees Work at Ravenbhel Pharmaceuticals?
Ravenbhel Pharmaceuticals has a workforce of 122 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ravenbhel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravenbhel Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
